0000929638-25-002338.txt : 20250627 0000929638-25-002338.hdr.sgml : 20250627 20250627093944 ACCESSION NUMBER: 0000929638-25-002338 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20250627 DATE AS OF CHANGE: 20250627 EFFECTIVENESS DATE: 20250627 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MPM BioImpact Innovations Equities Fund, LTD. CENTRAL INDEX KEY: 0002028861 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-517386 FILM NUMBER: 251082704 BUSINESS ADDRESS: STREET 1: C/O OGIER GLOBAL (CAYMAN) LIMITED STREET 2: 80 NEXUS WAY, CAMANA BAY CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-9009 BUSINESS PHONE: 617-425-9200 MAIL ADDRESS: STREET 1: C/O OGIER GLOBAL (CAYMAN) LIMITED STREET 2: 80 NEXUS WAY, CAMANA BAY CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-9009 D/A 1 primary_doc.xml X0708 D/A LIVE 0002028861 MPM BioImpact Innovations Equities Fund, LTD. C/O OGIER GLOBAL (CAYMAN) LIMITED 89 Nexus Way, Camana Bay GRAND CAYMAN E9 CAYMAN ISLANDS KY1-9009 1 345-949-9876 CAYMAN ISLANDS None None Other Cayman Islands Exempted Company true 2024 Alan Kelly One Nexus Way Camana Bay, Suite 5B201 Grand Cayman E9 CAYMAN ISLANDS KY1-1103 Director Nicole Ramroop One Nexus Way Camana Bay, Suite 5B201 Grand Cayman E9 CAYMAN ISLANDS KY1-1103 Director Brendan Furey c/o MPM BioImpact LLC 399 Boylston Street, Suite 1100 Boston MA MASSACHUSETTS 02116 Director Pooled Investment Fund Hedge Fund true Decline to Disclose 3C.7 06b 3C true 0000929638-24-002294 2024-06-03 true true true true Redeemable Shares. The Board of Directors, in its sole discretion, may accept a subscription for a lesser amount than the $1,000,000 minimum. false 1000000 Indefinite 25407242 Indefinite The total amount sold and number of investors reflect only sales to residents of the U.S. false 7 0 0 0 false MPM BioImpact Innovations Equities Fund, LTD. /s/ Brendan Furey Brendan Furey Director of the Issuer 2025-06-25